2026 Q2 Portfolio Activity
In 2026 Q2, KVP Capital Advisors, LP maintained a portfolio of 38 distinct positions. The most significant new addition was TANDEM DIABETES CARE INC, now representing 3.33% of the total fund value. They heavily accumulated shares in ERASCA INC, increasing the position by 33.8%. Conversely, KVP Capital Advisors, LP completely exited their position in TERNS PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
KVP Capital Advisors, LP
AUM $136M
Total Positions
38
Quarter
2026 Q2
Top Holding
PRAX (10.5%)
Top 10 Concentration
57.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-38 of 38
KVP Capital Advisors, LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 10.54% | 10.32% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
42,900 | $14,362,491 |
$294.74
+19.4%
|
2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
WHWK
WHITEHAWK THERA...
|
Healthcare | 7.28% | 5.58% |
#2
1
Prev: #3
|
5.4 |
—
|
no change | no change |
P
S
|
2,165,997 | $9,920,266 |
$2.42
+90.1%
|
2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
ERAS
ERASCA INC
|
Healthcare | 6.12% | 4.11% |
#3
4
Prev: #7
|
5.9 |
—
|
115,000 | 33.8% |
P
S
|
455,000 | $8,335,600 |
$16.72
-3.2%
|
2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 5.67% | 3.69% |
#4
4
Prev: #8
|
3.8 |
—
|
no change | no change |
P
S
|
414,000 | $7,721,100 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 5.52% | 4.22% |
#5
Prev: #5
|
3.7 |
—
|
no change | no change |
P
S
|
226,575 | $7,522,290 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 5.28% | 3.60% |
#6
3
Prev: #9
|
3.1 |
—
|
no change | no change |
P
S
|
230,264 | $7,198,053 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 4.92% | 2.71% |
#7
7
Prev: #14
|
3.0 |
—
|
no change | no change |
P
S
|
121,524 | $6,708,125 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 4.77% | 4.17% |
#8
2
Prev: #6
|
2.9 |
—
|
no change | no change |
P
S
|
53,000 | $6,496,740 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 3.97% | 3.13% |
#9
2
Prev: #11
|
2.6 |
—
|
no change | no change |
P
S
|
133,000 | $5,403,790 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 3.33% | — |
#10
Prev: #—
|
4.8 |
—
|
301,000 | — |
NEW
|
301,000 | $4,542,090 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 3.13% | 2.78% |
#11
2
Prev: #13
|
2.3 |
—
|
no change | no change |
P
S
|
58,250 | $4,260,405 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SVRA
SAVARA INC
|
Healthcare | 2.74% | 2.47% |
#12
3
Prev: #15
|
2.1 |
—
|
no change | no change |
P
S
|
605,280 | $3,728,525 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 2.60% | — |
#13
Prev: #—
|
4.5 |
—
|
102,000 | — |
NEW
|
102,000 | $3,543,480 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
INSM
INSMED INC
|
Healthcare | 2.23% | 3.48% |
#14
4
Prev: #10
|
1.9 |
—
|
no change | no change |
P
S
|
28,497 | $3,038,350 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 2.22% | 1.02% |
#15
14
Prev: #29
|
1.9 |
—
|
no change | no change |
P
S
|
462,355 | $3,019,178 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 2.18% | 1.98% |
#16
2
Prev: #18
|
1.9 |
—
|
no change | no change |
P
S
|
79,700 | $2,970,419 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 2.16% | 1.90% |
#17
3
Prev: #20
|
1.9 |
—
|
no change | no change |
P
S
|
300,000 | $2,946,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 2.16% | 4.57% |
#18
14
Prev: #4
|
0.9 |
—
|
-24,200 | -66.9% |
P
S
|
12,000 | $2,937,240 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DSGN
DESIGN THERAPEU...
|
Healthcare | 1.96% | — |
#19
Prev: #—
|
4.3 |
—
|
185,000 | — |
NEW
|
185,000 | $2,676,950 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 1.89% | 2.10% |
#20
4
Prev: #16
|
1.8 |
—
|
no change | no change |
P
S
|
4,750 | $2,573,693 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.82% | 1.65% |
#21
3
Prev: #24
|
1.7 |
—
|
no change | no change |
P
S
|
45,000 | $2,475,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 1.74% | 1.57% |
#22
3
Prev: #25
|
1.7 |
—
|
no change | no change |
P
S
|
230,423 | $2,375,661 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.69% | 1.83% |
#23
2
Prev: #21
|
1.7 |
—
|
no change | no change |
P
S
|
125,000 | $2,296,250 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 1.67% | — |
#24
Prev: #—
|
4.2 |
—
|
84,168 | — |
NEW
|
84,168 | $2,270,853 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 1.64% | 1.73% |
#25
3
Prev: #22
|
1.7 |
—
|
no change | no change |
P
S
|
31,813 | $2,233,273 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 1.63% | 2.02% |
#26
9
Prev: #17
|
0.7 |
—
|
-52,000 | -57.1% |
P
S
|
39,000 | $2,215,590 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 1.62% | 1.66% |
#27
4
Prev: #23
|
1.6 |
—
|
no change | no change |
P
S
|
373,128 | $2,201,455 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 1.42% | — |
#28
Prev: #—
|
4.1 |
—
|
200,000 | — |
NEW
|
200,000 | $1,940,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.38% | 1.45% |
#29
2
Prev: #27
|
1.6 |
—
|
no change | no change |
P
S
|
26,900 | $1,877,889 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 1.24% | 1.98% |
#30
11
Prev: #19
|
3.5 |
—
|
271,000 | 54.2% |
P
S
|
771,000 | $1,688,490 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CABA
CABALETTA BIO I...
|
Healthcare | 1.15% | 1.02% |
#31
3
Prev: #28
|
1.5 |
—
|
no change | no change |
P
S
|
505,431 | $1,571,890 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 1.03% | 0.98% |
#32
2
Prev: #30
|
1.4 |
—
|
no change | no change |
P
S
|
32,700 | $1,403,157 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 0.76% | — |
#33
Prev: #—
|
3.8 |
—
|
150,000 | — |
NEW
|
150,000 | $1,041,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CELC
CELCUITY INC
|
Healthcare | 0.31% | 0.34% |
#34
3
Prev: #31
|
1.1 |
—
|
no change | no change |
P
S
|
4,000 | $418,480 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
VYNE
VYNE THERAPEUTI...
|
Healthcare | 0.24% | 0.22% |
#35
3
Prev: #32
|
1.1 |
—
|
no change | no change |
P
S
|
500,551 | $325,709 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.00% | 1.49% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-59,700 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 0.00% | 2.92% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-40,200 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 0.00% | 17.32% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-440,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-38 of 38 holdings